Top

Published in:

Open Access 01-12-2021 | Multiple Sclerosis | Research article

Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population

Authors: Claudia Sousa, Mariana Rigueiro-Neves, Ana Margarida Passos, Aristides Ferreira, Maria José Sá, on behalf of the Group for Validation of the BRBN-T in the Portuguese MS Population

Published in: BMC Neurology | Issue 1/2021

Abstract

Background

The Brief Repeatable Battery of Neuropsychological Tests (BRBN-T) is one of the most sensitive and used measures for detecting cognitive impairment in Multiple Sclerosis (MS).

Objective

The aim of this study was to adapt and validate this battery to the Portuguese population of MS patients.

Methods

The Portuguese version of the BRBN-T was applied to a stratified control national sample of 326 individuals considering sex, age, educational level and geographic location and also a clinical sample of 115 MS patients from several national hospitals. Through the exploration of its psychometrics properties, the Portuguese BRBN-T norms were produced.

Results

The normative data is presented as a regression-based formula to adjust test scores for gender, education and age, and the results reveal the BRBN-T has the ability to differentiate between MS patients and healthy participant’s cognitive performance.

Conclusion

This study demonstrated in our clinical population a good ability to detect cognitive impairment. Its clearly contributed to reinforcing the neuropsychological assessment in Portugal in patients with MS, by providing a new set of instruments, which can be used in the clinical practice, and in future studies. Moreover, it will allow a rigorous and precise support in relation to neuropsychological assessment for future longitudinal studies and clinical trials.

Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive impairment in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41(5):685–91. https://doi.org/10.1212/WNL.41.5.685.CrossRef

Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006;245:1–2.CrossRef

Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol. 2011;24(3):244–9. https://doi.org/10.1097/WCO.0b013e328346a43b.CrossRefPubMed

Glanz BI, Holand M, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler. 2007;13(8):1004–10. https://doi.org/10.1177/1352458507077943.

Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A, et al. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology. 2012;78(5):309–14. https://doi.org/10.1212/WNL.0b013e31824528c9.

Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler. 2010;16(1):62–7. https://doi.org/10.1177/1352458509350311.

Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol. 2001;58(10):1602–6. https://doi.org/10.1001/archneur.58.10.1602.CrossRefPubMed

Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, the MSCOI Study Group, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123–36. https://doi.org/10.1177/1352458517694432.

Sá MJ, Kobelt G, Berg J, Capsa D, Dalén J. European Multiple Sclerosis Platform. New insights into the burden and costs of multiple sclerosis in Europe: Results for Portugal. Multiple Sclerosis. 2017;23(2-suppl):143–54.CrossRef

10.

Costa D, Sá MJ, Calheiros JM. Social characteristics and quality of life of Portuguese multiple Sclerosis patients. Neurol Ther. 2013;2(1–2):43–56.CrossRef

11.

Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7(5):340–4. https://doi.org/10.1177/135245850100700511.CrossRefPubMed

12.

Rao SM, Cognitive Function Study Group N. A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis. New York: National Multiple Sclerosis Society; 1990.

13.

Bobholz AJ, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol. 2003;16(3):283–8. https://doi.org/10.1097/01.wco.0000073928.19076.84.CrossRefPubMed

14.

Lensch E, Matzke M, Petereit HF, et al. Identification and management of cognitive disorders in multiple sclerosis: a consensus approach. J Neurol. 2006;253:S29–31.CrossRef

15.

Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002;16(3):381–97. https://doi.org/10.1076/clin.16.3.381.13859.CrossRefPubMed

16.

Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006;12(12):549–58.PubMed

17.

Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler. 2012;18(6):891–8. https://doi.org/10.1177/1352458511431076.

18.

Sousa C, Neves MR, Miranda T, Alegria P, Vale J, Passos AM, et al. Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis. BMC Neurol. 2018;18:172. https://doi.org/10.1186/s12883-018-1175-4.

19.

Moccia M, Lanzillo R, Palldino R, Chu-Mei Chang K, Costabile T, Russo C, et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mul Scler. 2016;22:659–67. https://doi.org/10.1177/2F1352458515599075.

20.

Sousa C, Neves M, Passos AM, Ferreira A, et al. Paced auditory serial addition test (pasat 3.0 s): demographically corrected norms for the Portuguese population. Appl Neuropsychol. 2017;23:1–7. https://doi.org/10.1080/23279095.2017.1323752.CrossRef

21.

Neves M, Sousa C, Passos AM, Ferreira A, et al. Verbal Selective Reminding Test (six trial administration) Portuguese normative data. Appl Neuropsychol. 2017;30(6):1–9. https://doi.org/10.1080/23279095.2017.1336712.CrossRef

22.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;17(2). https://doi.org/10.1016/S1474-4422(17)30470-2.

23.

Kurzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.CrossRef

24.

Instituto Nacional de Estatística (2011). Portal de estatísticas oficiais (Portuguese Official Statistics). Retrieved from http://www.ine.pt.

25.

Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24(11):1019–25. https://doi.org/10.1212/WNL.24.11.1019.CrossRefPubMed

26.

Smith A. Symbol digit modalities test: manual. Los Angeles: Western Psychological Services; 1982.

27.

Neves M, Passos AM, Ferreira A, Sousa C, et al. BRBN-T validation: adaptation of the selective reminding test and word list generation. Arquivos Neuropsiquiatria. 2015;73(10):867–72. https://doi.org/10.1590/0004-282X20150134.CrossRef

28.

Diehr MC, Cherner M, Wolfson TJ, Miller SW, Grant I, Heaton RW. The 50 and 100-item short forms of the paced auditory serial addition task (PASAT): demographically corrected norms and comparisons with the full PASAT in Normal and clinical samples. J Clin Exp Neuropsychol. 2003;25(4):571–85. https://doi.org/10.1076/jcen.25.4.571.13876.CrossRefPubMed

29.

Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology. 2009;73(7):498–503. https://doi.org/10.1212/WNL.0b013e3181b351fd.

30.

Portaccio E, Goretti B, Zipoli V, Siracusa G, Sorbi S, Amato MP. A short version of Rao’s brief repeatable battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol. 2009;23(2):268–75. https://doi.org/10.1080/13854040801992815.CrossRefPubMed

31.

Hansen S, Muenssinger J, Kronhofmann S, Lautenbacher S, Oschmann P, Keune P. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s brief repeatable battery. BMC Neurol. 2015;15(1):246. https://doi.org/10.1186/s12883-015-0497-8.CrossRefPubMedPubMedCentral

32.

Branco M, Alves I, Silva AM, Pinheiro J, Sá MJ, Correia I, et al. The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study. BMC Neurol. 2020. https://doi.org/10.1186/s12883-020-01755-8.

33.

McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17(8):647–50. https://doi.org/10.1046/j.1525-1497.2002.10750.x.CrossRefPubMedCentral

34.

Marrie RA, Whitehouse CE, Patel R, et al. Performance of regression-based norms for cognitive functioning of persons with multiple Sclerosis in an independent sample. Front Neul. 2020;11:621010. https://doi.org/10.3389/2Ffneur.2020.621010.CrossRef

35.

Boringa JB, Lazeron RHC, Reuling IEW, Adèr HJ, Pfennings LEMA, Lindeboom J, et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler. 2001;7(4):263–7. https://doi.org/10.1177/135245850100700409.

36.

Obradovic D, Petrovic M, Antanasijevic I, Marinkovic J, Stojanovic T, Obradovic S. The brief repeatable battery: psychometrics and normative values with age, education and gender corrections in a Serbian population. Neurol Sci. 2012;33:1369–74. https://doi.org/10.1007/s10072-012-1099-5.CrossRefPubMed

37.

Yoshii F, Takagi S, Nagata E, Hasegawa Y, Kunika N, Maki F, et al. Cognitive impairment of Japanese multiple sclerosis patients: follow-up study using BRB-N assessment tool. J Neurol Sci. 2015;359(2015):323–7. https://doi.org/10.1016/j.jns.2015.11.002.

38.

Falco F, et al. Normative values of the Rao’s brief repeatable battery in an Italian young adolescent population: the influence of age, gender, and education. Neurol Sci. 2019. https://doi.org/10.1007/s10072-019-3712-3.

39.

Scherer P, Baum K, Bauer H, Gohler H. Normalization of the brief repeatable battery of neuropsychological tests (BRBN) for German speaking regions. Application in relapsing remitting and secondary progressive multiple sclerosis patients. Nervenarzt. 2004;75:984–90.CrossRef

40.

Amato MP, Portaccio E, Zipoli V, Ricchiuti L, De Caro MF, Patti F, et al. The Rao’s brief repeatable battery and Stroop test: normative values with age, education and gender corrections in an Italian population. Mult Scler. 2006;12(6):787–93. https://doi.org/10.1177/1352458506070933.

Title: Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population
Authors: Claudia Sousa
Mariana Rigueiro-Neves
Ana Margarida Passos
Aristides Ferreira
Maria José Sá
on behalf of the Group for Validation of the BRBN-T in the Portuguese MS Population
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Multiple Sclerosis
Published in: BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-021-02193-w

2024 ASCO Annual Meeting

Springer Medicine

Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population

Abstract

Background

Objective

Methods

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

20-hydroxyeiscosatetraenoic acid may be as a predictor of malignant middle cerebral artery infarction in patients with massive middle cerebral artery infarction

Development of a patient-reported outcome measure for patients who have recovered from a subarachnoid hemorrhage: the “questionnaire for the screening of symptoms in aneurysmal subarachnoid hemorrhage” (SOS-SAH)

Evolution and prediction of mismatch between observed and perceived upper limb function after stroke: a prospective, longitudinal, observational cohort study

Serum copper decrease and cerebellar atrophy in patients with nitrous oxide-induced subacute combined degeneration: two cases report

Recurrent primary pyogenic ventriculitis in an adult woman: a case report

Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage